Perspectives of primary care clinicians on teratogenic risk counseling

Eleanor Schwarz, Aimee Santucci, Sonya Borrero, Aletha Y. Akers, Cara Nikolajski, Melanie A. Gold

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

BACKGROUND: Women of childbearing age are commonly prescribed medications by primary care providers (PCPs) that may cause birth defects if used during pregnancy. METHODS: To identify what PCPs perceive as barriers to and potential facilitators of providing counseling to women of childbearing age when teratogenic medications are prescribed, we conducted eight focus groups with 48 PCPs recruited from four clinical settings in Pittsburgh, Pennsylvania. We explored PCPs' experiences counseling women about teratogenic medications. Each focus group was audio-recorded, transcribed, and coded using a grounded theory approach by three independent coders. RESULTS: PCPs feel responsible for counseling women when they prescribe medications that may cause birth defects, but note difficulties identifying clinically relevant sources of information on teratogenicity. Other barriers to providing counseling include limited visit times and lack of reimbursement for preconception or teratogenic risk counseling. PCPs find it challenging to identify patients who may become pregnant and who therefore need contraceptive and/or teratogenic risk counseling. PCPs expressed a desire for online resources that could be used when explaining medication risks to patients. PCPs feel that the development of patient information materials, electronic decision support tools, clinical care systems that routinely assess patients' pregnancy risk, and changes in the reimbursement structure may facilitate counseling patients about teratogenic risks. CONCLUSIONS: PCPs perceive themselves as playing an important role in providing their patients information on risk of medication-induced birth defects. To ensure safe prescription of teratogenic medications, PCPs suggest interventions at both the clinic and healthcare system levels.

Original languageEnglish (US)
Pages (from-to)858-863
Number of pages6
JournalBirth Defects Research Part A - Clinical and Molecular Teratology
Volume85
Issue number10
DOIs
StatePublished - Oct 1 2009
Externally publishedYes

Fingerprint

Counseling
Primary Health Care
Focus Groups
Clinical Decision Support Systems
Pregnancy
Contraceptive Agents
Prescriptions
Delivery of Health Care

Keywords

  • Birth defects
  • Counseling
  • Medications
  • Primary care
  • Qualitative
  • Teratogens

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Embryology
  • Developmental Biology

Cite this

Perspectives of primary care clinicians on teratogenic risk counseling. / Schwarz, Eleanor; Santucci, Aimee; Borrero, Sonya; Akers, Aletha Y.; Nikolajski, Cara; Gold, Melanie A.

In: Birth Defects Research Part A - Clinical and Molecular Teratology, Vol. 85, No. 10, 01.10.2009, p. 858-863.

Research output: Contribution to journalArticle

Schwarz, Eleanor ; Santucci, Aimee ; Borrero, Sonya ; Akers, Aletha Y. ; Nikolajski, Cara ; Gold, Melanie A. / Perspectives of primary care clinicians on teratogenic risk counseling. In: Birth Defects Research Part A - Clinical and Molecular Teratology. 2009 ; Vol. 85, No. 10. pp. 858-863.
@article{8d12788bab4f483eaf0335057e5d0f93,
title = "Perspectives of primary care clinicians on teratogenic risk counseling",
abstract = "BACKGROUND: Women of childbearing age are commonly prescribed medications by primary care providers (PCPs) that may cause birth defects if used during pregnancy. METHODS: To identify what PCPs perceive as barriers to and potential facilitators of providing counseling to women of childbearing age when teratogenic medications are prescribed, we conducted eight focus groups with 48 PCPs recruited from four clinical settings in Pittsburgh, Pennsylvania. We explored PCPs' experiences counseling women about teratogenic medications. Each focus group was audio-recorded, transcribed, and coded using a grounded theory approach by three independent coders. RESULTS: PCPs feel responsible for counseling women when they prescribe medications that may cause birth defects, but note difficulties identifying clinically relevant sources of information on teratogenicity. Other barriers to providing counseling include limited visit times and lack of reimbursement for preconception or teratogenic risk counseling. PCPs find it challenging to identify patients who may become pregnant and who therefore need contraceptive and/or teratogenic risk counseling. PCPs expressed a desire for online resources that could be used when explaining medication risks to patients. PCPs feel that the development of patient information materials, electronic decision support tools, clinical care systems that routinely assess patients' pregnancy risk, and changes in the reimbursement structure may facilitate counseling patients about teratogenic risks. CONCLUSIONS: PCPs perceive themselves as playing an important role in providing their patients information on risk of medication-induced birth defects. To ensure safe prescription of teratogenic medications, PCPs suggest interventions at both the clinic and healthcare system levels.",
keywords = "Birth defects, Counseling, Medications, Primary care, Qualitative, Teratogens",
author = "Eleanor Schwarz and Aimee Santucci and Sonya Borrero and Akers, {Aletha Y.} and Cara Nikolajski and Gold, {Melanie A.}",
year = "2009",
month = "10",
day = "1",
doi = "10.1002/bdra.20599",
language = "English (US)",
volume = "85",
pages = "858--863",
journal = "Teratology",
issn = "1542-0752",
publisher = "Wiley-Liss Inc.",
number = "10",

}

TY - JOUR

T1 - Perspectives of primary care clinicians on teratogenic risk counseling

AU - Schwarz, Eleanor

AU - Santucci, Aimee

AU - Borrero, Sonya

AU - Akers, Aletha Y.

AU - Nikolajski, Cara

AU - Gold, Melanie A.

PY - 2009/10/1

Y1 - 2009/10/1

N2 - BACKGROUND: Women of childbearing age are commonly prescribed medications by primary care providers (PCPs) that may cause birth defects if used during pregnancy. METHODS: To identify what PCPs perceive as barriers to and potential facilitators of providing counseling to women of childbearing age when teratogenic medications are prescribed, we conducted eight focus groups with 48 PCPs recruited from four clinical settings in Pittsburgh, Pennsylvania. We explored PCPs' experiences counseling women about teratogenic medications. Each focus group was audio-recorded, transcribed, and coded using a grounded theory approach by three independent coders. RESULTS: PCPs feel responsible for counseling women when they prescribe medications that may cause birth defects, but note difficulties identifying clinically relevant sources of information on teratogenicity. Other barriers to providing counseling include limited visit times and lack of reimbursement for preconception or teratogenic risk counseling. PCPs find it challenging to identify patients who may become pregnant and who therefore need contraceptive and/or teratogenic risk counseling. PCPs expressed a desire for online resources that could be used when explaining medication risks to patients. PCPs feel that the development of patient information materials, electronic decision support tools, clinical care systems that routinely assess patients' pregnancy risk, and changes in the reimbursement structure may facilitate counseling patients about teratogenic risks. CONCLUSIONS: PCPs perceive themselves as playing an important role in providing their patients information on risk of medication-induced birth defects. To ensure safe prescription of teratogenic medications, PCPs suggest interventions at both the clinic and healthcare system levels.

AB - BACKGROUND: Women of childbearing age are commonly prescribed medications by primary care providers (PCPs) that may cause birth defects if used during pregnancy. METHODS: To identify what PCPs perceive as barriers to and potential facilitators of providing counseling to women of childbearing age when teratogenic medications are prescribed, we conducted eight focus groups with 48 PCPs recruited from four clinical settings in Pittsburgh, Pennsylvania. We explored PCPs' experiences counseling women about teratogenic medications. Each focus group was audio-recorded, transcribed, and coded using a grounded theory approach by three independent coders. RESULTS: PCPs feel responsible for counseling women when they prescribe medications that may cause birth defects, but note difficulties identifying clinically relevant sources of information on teratogenicity. Other barriers to providing counseling include limited visit times and lack of reimbursement for preconception or teratogenic risk counseling. PCPs find it challenging to identify patients who may become pregnant and who therefore need contraceptive and/or teratogenic risk counseling. PCPs expressed a desire for online resources that could be used when explaining medication risks to patients. PCPs feel that the development of patient information materials, electronic decision support tools, clinical care systems that routinely assess patients' pregnancy risk, and changes in the reimbursement structure may facilitate counseling patients about teratogenic risks. CONCLUSIONS: PCPs perceive themselves as playing an important role in providing their patients information on risk of medication-induced birth defects. To ensure safe prescription of teratogenic medications, PCPs suggest interventions at both the clinic and healthcare system levels.

KW - Birth defects

KW - Counseling

KW - Medications

KW - Primary care

KW - Qualitative

KW - Teratogens

UR - http://www.scopus.com/inward/record.url?scp=70350302867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350302867&partnerID=8YFLogxK

U2 - 10.1002/bdra.20599

DO - 10.1002/bdra.20599

M3 - Article

C2 - 19591115

AN - SCOPUS:70350302867

VL - 85

SP - 858

EP - 863

JO - Teratology

JF - Teratology

SN - 1542-0752

IS - 10

ER -